Clinic of Endocrinology, University Hospital "Alexandrovska", Medical University - Sofia, Sofia, Bulgaria.
Clinic of Neurology, University Hospital "Alexandrovska", Medical University - Sofia, Sofia, Bulgaria.
Prim Care Diabetes. 2020 Feb;14(1):47-52. doi: 10.1016/j.pcd.2019.05.003. Epub 2019 May 29.
The aim of this study was to investigate the role of Sudoscan asymmetry parameters in the diabetic foot.
In this study we included 165 participants: 84 type 2 diabetes patients divided into three HbA1c matched groups - group 1: newly diagnosed diabetics (n = 31), group 2: people with longer diabetes duration and established neuropathy (n = 33), group 3: patients with diabetic foot ulcer (n = 20), and a control group of 81 people with prediabetes. All subjects underwent peripheral sudomotor evaluation using Sudoscan device (Impeto Medical, Paris).
Patients with diabetic foot had significantly higher Sudoscan feet asymmetry (19.6%) compared to those with only diabetic neuropathy (7.9%), compared to the group with newly diagnosed diabetes (7.44%), and compared to controls (2.5%). This test has shown a good discriminative value (with a threshold of 9.5%) for diabetic foot with area under the ROC curve of 0.955 (p = 0.001). Additionally, in a regression model feet asymmetry proved its predictive value for participants with diabetic foot.
In this study Sudoscan feet asymmetry proved to be a novel discriminator and predictor for diabetic foot patients. It might be considered as a marker for early damage in the neuropathy evaluation protocol.
本研究旨在探讨 Sudoscan 不对称参数在糖尿病足中的作用。
本研究纳入了 165 名参与者:84 名 2 型糖尿病患者分为三组 HbA1c 匹配组 - 组 1:新诊断的糖尿病患者(n=31),组 2:糖尿病病程较长且已发生神经病变的患者(n=33),组 3:糖尿病足溃疡患者(n=20),和 81 名糖尿病前期患者的对照组。所有受试者均使用 Sudoscan 设备(Impeto Medical,巴黎)进行外周排汗功能评估。
与仅有糖尿病神经病变的患者(7.9%)、新诊断的糖尿病患者(7.44%)相比,糖尿病足患者的 Sudoscan 足部不对称性(19.6%)明显更高,与对照组(2.5%)相比也是如此。该检测对糖尿病足具有良好的鉴别价值(阈值为 9.5%),ROC 曲线下面积为 0.955(p=0.001)。此外,在回归模型中,足部不对称性证明了其对糖尿病足患者的预测价值。
本研究中,Sudoscan 足部不对称性被证明是糖尿病足患者的一种新的鉴别和预测因素。它可能被认为是神经病变评估方案中早期损伤的标志物。